Bispecific T cell engager therapy for refractory rheumatoid arthritis.
Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, Wacker J, Wilhelm A, Auger JP, Pachowsky M, Eckstein M, Alivernini S, Zoli A, Krönke G, Uderhardt S, Bozec A, D'Agostino MA, Schett G, Grieshaber-Bouyer R.
Nat Med. 2024 Jun;30(6):1593-1601. doi: 10.1038/s41591-024-02964-1. Epub 2024 Apr 26.
Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases.
Liu JC, Zhang K, Zhang X, Guan F, Zeng H, Kubo M, Lee P, Candotti F, James LK, Camara NOS, Benlagha K, Lei JH, Forsman H, Yang L, Xiao W, Liu Z, Liu CH.
MedComm (2020). 2024 Aug 13;5(8):e662. doi: 10.1002/mco2.662. eCollection 2024 Aug.
Immunodeficiency.
Justiz Vaillant AA, Qurie A.
2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Kidney Involvement in Autoinflammatory Diseases.
Zhang C, Peng J, Liu Z, Zhou Q.
Kidney Dis (Basel). 2023 Feb 28;9(3):157-172. doi: 10.1159/000529917. eCollection 2023 May.
Increased proportion of a CD38(high)IgD(+) B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sjogren's syndrome.
Ishioka-Takei E, Yoshimoto K, Suzuki K, Nishikawa A, Yasuoka H, Yamaoka K, Takeuchi T.
Clin Immunol. 2018 Feb;187:85-91. doi: 10.1016/j.clim.2017.10.008. Epub 2017 Oct 20.
High IgD could be a nonpathogenetic diagnostic marker of the hyper-IgD and periodic fever syndrome.
de Dios García-Díaz J, Alvarez-Blanco MJ.
Ann Allergy Asthma Immunol. 2001 May;86(5):587. doi: 10.1016/s1081-1206(10)62909-2.
[Analysis of MVK gene variant in a child with high IgD syndrome caused by mevalonate kinase deficiency].
Wang J, Wei X, Tao Z.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022 Apr 10;39(4):413-416. doi: 10.3760/cma.j.cn511374-20210110-00025.
Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group.
Drenth JP, Haagsma CJ, van der Meer JW.
Medicine (Baltimore). 1994 May;73(3):133-44.
Phenotypic, transcriptomic, and spatial characterization of CD45RB+ naïve mature B cells: Implications in Sjögren's disease.
Boudigou M, Frutoso M, Hémon P, Le Dantec C, Chatzis L, Devauchelle V, Jamin C, Cornec D, Pers JO, Le Pottier L, Hillion S.
Clin Immunol. 2024 Nov;268:110378. doi: 10.1016/j.clim.2024.110378. Epub 2024 Oct 10.
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.
Triggianese P, Vitale A, Lopalco G, Mayrink Giardini HA, Ciccia F, Al-Maghlouth I, Ruscitti P, Sfikakis PP, Iannone F, de Brito Antonelli IP, Patrone M, Asfina KN, Di Cola I, Laskari K, Gaggiano C, Tufan A, Sfriso P, Dagna L, Giacomelli R, Hinojosa-Azaola A, Ragab G, Fotis L, Direskeneli H, Spedicato V, Dagostin MA, Iacono D, Ali HH, Cipriani P, Sota J, Kardas RC, Bindoli S, Campochiaro C, Navarini L, Gentileschi S, Martín-Nares E, Torres-Ruiz J, Saad MA, Kourtesi K, Alibaz-Oner F, Sevik G, Iagnocco A, Makowska J, Govoni M, Monti S, Maggio MC, La Torre F, Del Giudice E, Hernández-Rodríguez J, Bartoloni E, Emmi G, Chimenti MS, Maier A, Simonini G, Conti G, Olivieri AN, Tarsia M, De Paulis A, Lo Gullo A, Więsik-Szewczyk E, Viapiana O, Ogunjimi B, Tharwat S, Erten S, Nuzzolese R, Karamanakos A, Frassi M, Conforti A, Caggiano V, Marino A, Sebastiani GD, Gidaro A, Tombetti E, Carubbi F, Rubegni G, Cartocci A, Balistreri A, Fabiani C, Frediani B, Cantarini L.
Intern Emerg Med. 2023 Nov;18(8):2231-2243. doi: 10.1007/s11739-023-03408-3. Epub 2023 Oct 12.
